Your position:m.limatoxi.com >> EN >> EN >> Pharmaceutical News >> Taizhou Haisheng Pharmaceutical Co., Ltd. invested RMB 1.5 billion to start the project of high-end APIs preparations (ergosterol, vitamin D2 other products). >> article
 
Taizhou Haisheng Pharmaceutical Co., Ltd. invested RMB 1.5 billion to start the project of high-end APIs preparations (ergosterol, vitamin D2 other products).
Editor:xuezhe    Clicks:0    Date:2022-7-1 16:13:38
Keyword: vitamin D2
Healthoo Information:
 
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Relative Information
  • NHU Heilongjiang Vitamin C production line began to stop production ma...
  • The domestic price of vitamin C raw materials bottomed out, the export...
  • The vitamin B2 production line of Guangji Pharmaceutical (Mengzhou) Co...
  • In the summer of 2022, vitamin C enterprises have successively stopped...
  • The vitamin K3 production line of Mianyang Wainida Chemical Co., Ltd. ...
  • Garden Biological Co., Ltd. has basically completed the whole industry...
  • Brothers vitamin K3 production line is scheduled to stop production fo...
  • Vitamin B1 (nitrate)reference price
  • Vitamin B1 (hydrochloride)reference price
  • Vitamin B2 (feed) reference price
  • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463
    Baidu
    map